Abstract:Background: The role of cuproptosis, a phenomenon associated with tumor metabolism and immunological identification, remains underexplored, particularly in relation to the cancer-immunity cycle (CIC) network. This study aims to rigorously examine the impact of the cuproptosis-CIC nexus on immune reactions and prognostic outcomes in patients with breast cancer (BC), striving to establish a comprehensive prognostic model. Methods: In the study, we segregated data obtained from TCGA, GEO, and ICGC using CICs retrieved from the TIP database. We constructed a genetic prognostic framework using the LASSO-Cox model, followed by its validation through Cox proportional hazards regression. This framework's validity was further confirmed with data from ICGC and GEO. Explorations of the tumor microenvironment were carried out through the application of ESTIMATE and CIBERSORT algorithms, as well as machine learning techniques, to identify potential treatment strategies. Single-cell sequencing methods were utilized to delineate the spatial distribution of key genes within the various cell types in the tumor milieu. To explore the critical role of the identified CICs, experiments were conducted focusing on cell survival and migration abilities. Results: In our research, we identified a set of 4 crucial cuproptosis-CICs that have a profound impact on patient longevity and their response to immunotherapy. By leveraging these identified CICs, we constructed a predictive model that efficiently estimates patient prognoses. Detailed analyses at the single-cell level showed that the significance of CICs. Experimental approaches, including CCK-8, Transwell, and wound healing assays, revealed that the protein HSPA9 restricts the growth and movement of breast cancer cells. Furthermore, our studies using immunofluorescence techniques demonstrated that suppressing HSPA9 leads to a notable increase in ceramide levels. Conclusion: This research outlines a network of cuproptosis-CICs and constructs a predictive nomogram. Our model holds great promise for healthcare professionals to personalize treatment approaches for individuals with breast cancer. The work provides insights into the complex relationship between the cuproptosis-CIC network and the cancer immune microenvironment, setting the stage for novel approaches to cancer immunotherapy. By focusing on the essential gene HSPA9 within the cancer-immunity cycle, this strategy has the potential to significantly improve the efficacy of treatments against breast cancer.

CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer

IMPACT: A Web Server for Exploring Immunotherapeutic Predictive and Cancer Prognostic Biomarkers

TIP: A web server for resolving tumor immunophenotype profiling.

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy

Pan-cancer analysis of <i>KEAP1</i> mutations as biomarkers for immunotherapy outcomes

An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures

TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology

OSppc: A web server for online survival analysis using proteome of pan-cancers

IOBR2: Multidimensional Decoding Tumor Microenvironment for Immuno-Oncology Research

PCAS: an Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data

IOAT: an interactive tool for statistical analysis of omics data and clinical data

CanImmunother: a Manually Curated Database for Identification of Cancer Immunotherapies Associating with Biomarkers, Targets, and Clinical Effects.

Facts and hopes in using omics to advance combined immunotherapy strategies

ICM: a Web Server for Integrated Clustering of Multi-Dimensional Biomedical Data.

A Comprehensive Tool for Tumor Precision Medicine with Pharmaco-Omics Data Analysis

CVCDAP: an Integrated Platform for Molecular and Clinical Analysis of Cancer Virtual Cohorts.

PCIG: a web-based application to explore immune-genomics interactions across cancer types

BEST: a Web Application for Comprehensive Biomarker Exploration on Large-Scale Data in Solid Tumors

Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints

ExpOmics: a comprehensive web platform empowering biologists with robust multi-omics data analysis capabilities